International prostate symptom score is widely used to evaluate lower urinary tract symptoms in patients with benign prostatic hyperplasia. However, the questions can be difficult to understand for some patients, leading to inaccurate treatment decisions. A visual prostate symptom score could overcome this limitation, but should be further investigated.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Cornu, J. N., Cussenot, O., Haab, F. & Lukacs, B. A widespread population study of actual medical management of lower urinary tract symptoms related to benign prostatic hyperplasia across Europe and beyond official clinical guidelines. Eur. Urol. 58, 450–456 (2010).
Madersbacher, S. et al. EAU 2004 guidelines on assessment, therapy and follow-up of men with lower urinary tract symptoms suggestive of benign prostatic obstruction (BPH guidelines). Eur. Urol. 46, 547–554 (2004).
van der Walt, C. L., Heyns, C. F., Groeneveld, A. E., Edlin, R. S. & van Vuuren, S. P. Prospective comparison of a new visual prostate symptom score versus the international prostate symptom score in men with lower urinary tract symptoms. Urology 78, 17–20 (2011).
Rodrigues Netto, N. Jr et al. Latin American study on patient acceptance of the International Prostate Symptom Score (IPSS) in the evaluation of symptomatic benign prostatic hyperplasia. Urology 49, 46–49 (1997).
Luján Galán, M., Páez Borda, A., Martín Osés, E., Llanes González, L. & Berenguer Sánchez, A. The validity of the IPSS questionnaire in a sample of 262 patients with benign prostatic hyperplasia. Arch. Esp. Urol. 50, 847–853 (1997).
Cam, K., Senel, F., Akman, Y. & Erol, A. The efficacy of an abbreviated model of the International Prostate Symptom Score in evaluating benign prostatic hyperplasia. BJU Int. 91, 186–189 (2003).
Plante, M. et al. The international prostate symptom score: physician versus self-administration in the quantification of symptomatology. Urology 47, 326–328 (1996).
Shi, J., Sun, Z., Cai, T. & Yang, L. Development and validation of a quality-of-life scale for Chinese patients with benign prostatic hyperplasia. BJU Int. 94, 837–844 (2004).
Boyle, P. Cultural and linguistic validation of questionnaires for use in international studies: the nine-item BPH-specific quality-of-life scale. Eur. Urol. 32 (Suppl. 2), 50–52 (1997).
Ushijima, S. et al. Visual analog scale questionnaire to assess quality of life specific to each symptom of the International Prostate Symptom Score. J. Urol. 176, 665–671 (2006).
Author information
Authors and Affiliations
Ethics declarations
Competing interests
The author declares no competing financial interests.
Rights and permissions
About this article
Cite this article
Cam, K. How useful is a visual prostate symptom score for patients?. Nat Rev Urol 8, 536–537 (2011). https://doi.org/10.1038/nrurol.2011.137
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrurol.2011.137
This article is cited by
-
A simplified Italian translation of the international prostate symptom score twists the reality in the aging male with lower urinary tract symptoms
Prostate Cancer and Prostatic Diseases (2020)
